MBQ Pharma Inc.
San Juan, San Juan
- UEI
- ST1KRX8HTWM8
- CAGE
- 882J9
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 988 Av. Luis Muñoz Rivera, San Juan, 00927, Puerto Rico
- Website
- mbqpharma.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Changing the paradigm of breast cancer treatment: MBQ-167 as a first-in-class metastatic breast cancer therapeutic | Defense Health Agency | $4,398,726 |
Quick answers
Is MBQ Pharma Inc. registered in SAM.gov?
Yes. MBQ Pharma Inc.'s SAM.gov registration is active through October 21, 2026.
What is MBQ Pharma Inc.'s most recent federal award?
MBQ Pharma Inc.'s most recent federal grant award is Changing the paradigm of breast cancer treatment: MBQ-167 as a first-in-class metastatic breast cancer therapeutic (HT94252310381), from Defense Health Agency, on May 15, 2023.
On GovTribe
See MBQ Pharma Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors